Literature DB >> 19796747

Should a biopsy be recommended to confirm metastatic disease in women with breast cancer?

Eitan Amir, Mark Clemons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19796747     DOI： 10.1016/S1470-2045(09)70295-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  14 in total

Review 1.  The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?

Authors:  Mustafa Khasraw; Edi Brogi; Andrew D Seidman
Journal:  Curr Oncol Rep       Date:  2011-02       Impact factor: 5.075

2.  Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.

Authors:  Juan M Cejalvo; Eduardo Martínez de Dueñas; Patricia Galván; Susana García-Recio; Octavio Burgués Gasión; Laia Paré; Silvia Antolín; Rosella Martinello; Isabel Blancas; Barbara Adamo; Ángel Guerrero-Zotano; Montserrat Muñoz; Paolo Nucíforo; María Vidal; Ramón M Pérez; José I Chacón López-Muniz; Rosalía Caballero; Vicente Peg; Eva Carrasco; Federico Rojo; Charles M Perou; Javier Cortés; Vincenzo Adamo; Joan Albanell; Roger R Gomis; Ana Lluch; Aleix Prat
Journal:  Cancer Res       Date:  2017-03-01       Impact factor: 12.701

3.  Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer.

Authors:  Eitan Amir; Naomi Miller; William Geddie; Orit Freedman; Farrah Kassam; Christine Simmons; Maria Oldfield; George Dranitsaris; George Tomlinson; Andreas Laupacis; Ian F Tannock; Mark Clemons
Journal:  J Clin Oncol       Date:  2011-11-28       Impact factor: 44.544

4.  Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.

Authors:  Farrokh Dehdashti; Richard Laforest; Feng Gao; Rebecca L Aft; Carmen S Dence; Dong Zhou; Kooresh I Shoghi; Barry A Siegel; John A Katzenellenbogen; Michael J Welch
Journal:  J Nucl Med       Date:  2012-02-13       Impact factor: 10.057

Review 5.  Latest biopsy approach for suspected metastases in patients with breast cancer.

Authors:  Naoki Niikura; Bruno C Odisio; Yutaka Tokuda; Fraser W Symmans; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Nat Rev Clin Oncol       Date:  2013-10-22       Impact factor: 66.675

6.  Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis.

Authors:  Elsa Curtit; Virginie Nerich; Laura Mansi; Loic Chaigneau; Laurent Cals; Cristian Villanueva; Fernando Bazan; Philippe Montcuquet; Nathalie Meneveau; Sophie Perrin; Marie-Paule Algros; Xavier Pivot
Journal:  Oncologist       Date:  2013-05-30

7.  Hormone receptor and HER2 assessment in breast carcinoma metastatic to bone: A comparison between FNA cell blocks and decalcified core needle biopsies.

Authors:  Jennifer Zeng; Salvatore Piscuoglio; Gitika Aggarwal; Joanna Magda; Maria A Friedlander; Melissa Murray; Muzaffar Akram; Jorge S Reis-Filho; Britta Weigelt; Marcia Edelweiss
Journal:  Cancer Cytopathol       Date:  2019-12-28       Impact factor: 5.284

8.  Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

Authors:  Alastair M Thompson; Lee B Jordan; Philip Quinlan; Elizabeth Anderson; Anthony Skene; John A Dewar; Colin A Purdie
Journal:  Breast Cancer Res       Date:  2010-11-08       Impact factor: 6.466

9.  Clinicopathologic study in uterine cancer.

Authors:  I Vandenput
Journal:  Facts Views Vis Obgyn       Date:  2011

10.  The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.

Authors:  Laura Pizzuti; Maddalena Barba; Marco Mazzotta; Eriseld Krasniqi; Marcello Maugeri-Saccà; Teresa Gamucci; Rossana Berardi; Lorenzo Livi; Corrado Ficorella; Clara Natoli; Enrico Cortesi; Daniele Generali; Nicla La Verde; Alessandra Cassano; Emilio Bria; Luca Moscetti; Andrea Michelotti; Vincenzo Adamo; Claudio Zamagni; Giuseppe Tonini; Domenico Sergi; Daniele Marinelli; Giancarlo Paoletti; Silverio Tomao; Andrea Botticelli; Paolo Marchetti; Nicola Tinari; Antonino Grassadonia; Maria Rosaria Valerio; Rosanna Mirabelli; Maria Agnese Fabbri; Nicola D'Ostilio; Enzo Veltri; Domenico Corsi; Ornella Garrone; Ida Paris; Giuseppina Sarobba; Icro Meattini; Mirco Pistelli; Francesco Giotta; Vito Lorusso; Carlo Garufi; Antonio Russo; Marina Cazzaniga; Pietro Del Medico; Mario Roselli; Angela Vaccaro; Letizia Perracchio; Anna di Benedetto; Theodora Daralioti; Isabella Sperduti; Ruggero De Maria; Angelo Di Leo; Giuseppe Sanguineti; Gennaro Ciliberto; Patrizia Vici
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.